LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer
Abstract Objective Triple-Negative Breast Cancer (TNBC) is known for its aggressiveness and treatment challenges due to the absence of ER, PR, and HER2 receptors. Our work emphasizes the prognostic value of LCP1 (Lymphocyte cytosolic protein 1), which plays a crucial role in cell processes and immun...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2024-07-01
|
| Sraith: | BMC Immunology |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12865-024-00635-x |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|